FDA ponders loosening ELA process
FDA ponders loosening ELA process
WASHINGTON - The FDA announced that it is considering eliminating establishment licenses (ELAs) for well-characterized biotechnology products. It also announced the availiabiity of a Guidance Document Concerning Use of Pilot Manufacturing Facilities for the
